Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Colloids Surf B Biointerfaces ; 198: 111500, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33303318

RESUMO

Photodynamic therapy (PDT) has emerged as one of the most promising modalities to treat cancers. However, the hypoxic microenvironment in tumors severely limits the efficiency of PDT. IR780 is a near-infrared light activatable photosensitizer for PDT. It has attracted intensive attention owing to its intriguing properties such as mitochondria-targeting ability and fluorescence imaging capability. Nevertheless, its application in tumor treatment is hampered by its low aqueous solubility and poor stability. To address these obstacles, here we designed a novel hierarchical nanoplatform containing a uniquely stable high loading capacity oxygen carrier (perfluoropolyether, in short, PFPE) and IR780. This nanoplatform (IR780-P/W NE, in abbreviation for IR780-PFPE-in-water nanoemulsion) has no detectable dark cytotoxicity. It not only improves the aqueous solubility and stability of IR780, but also transports oxygen to relieve hypoxia and boosts the efficiency of near-infrared light triggered PDT via augmentation of reactive oxygen species generation. Particularly, the innovative nanosized oxygen carrier developed in this research, P/W NE, is a potential universal platform for loading hydrophobic photosensitizers (including but not limited to IR780), sonosensitizers, or radiosensitizers, and simultaneously improving the therapeutic efficacy. Our results highlight the intriguing potential of the developed nanoemulsions for mitigating tumor hypoxia and enhancing the efficiencies of oxygen-dependent therapies including PDT, sonodynamic therapy, radiotherapy, and so on.


Assuntos
Nanopartículas , Fotoquimioterapia , Linhagem Celular Tumoral , Humanos , Hipóxia , Indóis , Lasers , Oxigênio , Fármacos Fotossensibilizantes/farmacologia
2.
Chemosphere ; 90(7): 2181-6, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23246726

RESUMO

The enantioselective bioaccumulation and elimination of α-hexachlorocyclohexane (α-HCH) in loaches (Misgurnus anguillicaudatus) were studied for the first time. Valid chiral residue analysis methods for α-HCH enantiomers in water and loach samples were established using gas chromatography coupled with electron capture detector and a BGB-172 chiral column. A rapid accumulation process was found during the 39-d bioaccumulation experiment. The α-HCH in loaches reached its maximum on the fourth day, after which it fluctuated slightly, reflecting a balance between elimination and reuptake. The maximum bioaccumulation factor was 728 at the 10 µg L(-1) exposure level. The enantiomeric fraction (EF) values showed that the bioaccumulation was enantioselective with enantioenrichment of (+)-α-HCH in the loaches. The elimination experiment indicated that the degradation kinetics of α-HCH fitted a typical first-order kinetics model, and the half-life was about 5 d. Significant enantioselectivity was observed during the elimination process, with the EFs declining from higher than 0.5-0.39, suggesting (+)-α-HCH is preferentially biotransformed than (-)-α-HCH in loaches. The results reveal a high capacity for α-HCH bioconcentration by loaches and that biotransformation is the main route of decontamination.


Assuntos
Cipriniformes/metabolismo , Hexaclorocicloexano/metabolismo , Poluentes Químicos da Água/metabolismo , Animais , Biotransformação , Monitoramento Ambiental , Meia-Vida , Hexaclorocicloexano/análise , Hexaclorocicloexano/química , Poluentes Químicos da Água/análise , Poluentes Químicos da Água/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...